My dream script for this week: NP files the paperwork today with FDA for a coronavirus trial involving critically ill patients; then, on Wednesday or Thursday, we read a pre-market PR that FDA has approved Leronlimab coronavirus trials for both (1) mild to moderate patients AND for (2) critically ill patients. What a day that would be!